These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 27714756)

  • 1. Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.
    Zaiou M; El Amri H
    Clin Genet; 2017 Mar; 91(3):355-370. PubMed ID: 27714756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects of personalized medicine in cardiovascular diseases.
    Lenfant C
    Metabolism; 2013 Jan; 62 Suppl 1():S6-10. PubMed ID: 22999711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalized medicine: hope or hype?
    Salari K; Watkins H; Ashley EA
    Eur Heart J; 2012 Jul; 33(13):1564-70. PubMed ID: 22659199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments and future directions for the use of pharmacogenomics in cardiovascular disease treatments.
    Berinstein E; Levy A
    Expert Opin Drug Metab Toxicol; 2017 Sep; 13(9):973-983. PubMed ID: 28792790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
    Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
    Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomics and the prospects of existing and emerging therapeutics for cardiovascular diseases.
    Zaiou M; Benachour H; Marteau JB; Visvikis-Siest S; Siest G
    Curr Pharm Des; 2009; 15(27):3193-206. PubMed ID: 19754391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomics of cardiovascular disease.
    Manace LC; Godiwala TN; Babyatsky MW
    Mt Sinai J Med; 2009 Dec; 76(6):613-23. PubMed ID: 20014425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized genomes and cardiovascular disease.
    Musunuru K
    Cold Spring Harb Perspect Med; 2014 Sep; 5(1):a014068. PubMed ID: 25256177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized Management of Cardiovascular Disorders.
    Jain KK
    Med Princ Pract; 2017; 26(5):399-414. PubMed ID: 28898880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is personalized medicine a dream or a reality?
    Morse BL; Kim RB
    Crit Rev Clin Lab Sci; 2015 Feb; 52(1):1-11. PubMed ID: 25181036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics in Cardiovascular Medicine.
    Weeke PE
    Adv Pharmacol; 2018; 83():333-360. PubMed ID: 29801582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic insights into heart health: Exploring the genetic basis of cardiovascular disease.
    Safdar M; Ullah M; Wahab A; Hamayun S; Ur Rehman M; Khan MA; Khan SU; Ullah A; Din FU; Awan UA; Naeem M
    Curr Probl Cardiol; 2024 Jan; 49(1 Pt C):102182. PubMed ID: 37913933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular Pharmacogenomics--Implications for Patients With CKD.
    Cavallari LH; Mason DL
    Adv Chronic Kidney Dis; 2016 Mar; 23(2):82-90. PubMed ID: 26979147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics in cardiovascular disease: the challenge of moving from promise to realization: concepts discussed at the Canadian Network and Centre for Trials Internationally Network Conference (CANNeCTIN), June 2009.
    Joseph PG; Pare G; Ross S; Roberts R; Anand SS
    Clin Cardiol; 2014 Jan; 37(1):48-56. PubMed ID: 24105892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PHARMACOGENOMIC DETERMINANTS OF RESPONSE TO CARDIOVASCULAR DRUGS.
    Stankov KM; Stanimirov BG; Mikov MM
    Med Pregl; 2015; 68(7-8):259-65. PubMed ID: 26591639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision Cardiovascular Medicine: State of Genetic Testing.
    Giudicessi JR; Kullo IJ; Ackerman MJ
    Mayo Clin Proc; 2017 Apr; 92(4):642-662. PubMed ID: 28385198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of genetic data to guide therapy in arterial disease.
    Ross S; Nejat S; Paré G
    J Thromb Haemost; 2015 Jun; 13 Suppl 1():S281-9. PubMed ID: 26149037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing genome-driven personalized cardiology in clinical practice.
    Pasipoularides A
    J Mol Cell Cardiol; 2018 Feb; 115():142-157. PubMed ID: 29343412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Determinants of Response to Statins in Cardiovascular Diseases.
    Ghorbannezhad G; Mehrabadi S; Golampour-Shamkani N; Barjasteh A; Etesamizadeh P; Tayyebi M; Khazaei M; Hassanian SM; Ferns GA; Avan A
    Curr Cardiol Rev; 2024; 20(2):20-28. PubMed ID: 38204221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunities and Challenges in Cardiovascular Pharmacogenomics: From Discovery to Implementation.
    Roden DM; Van Driest SL; Wells QS; Mosley JD; Denny JC; Peterson JF
    Circ Res; 2018 Apr; 122(9):1176-1190. PubMed ID: 29700066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.